Consolidated Condensed Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Cash flows from operating activities:
Net loss	$ (157,021)	$ (109,829)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	62,628	57,845
Stock-based compensation expense	5,754	5,251
Deferred income taxes, net	(36,199)	(43,979)
Change in estimated fair value of contingent consideration	802	1,136
Foreign currency gain on intercompany loans (Note 5)	540	360
Other non-cash income, net	(3,237)	(797)
Changes in assets and liabilities:
Trade receivables, net	(102,387)	184,821
Inventories, net	745	(27,967)
Accounts payable and accrued liabilities	43,638	(26,505)
Deferred revenue	303,308	194,597
Income taxes payable - excess tax benefit from share award exercises	(1,279)	(2,535)
Income taxes payable - other	(359)	(9,405)
Other assets and liabilities, net	(3,598)	(12,158)
Net cash provided by operating activities	111,993	209,339
Cash flows from investing activities:
Capital expenditures	(30,168)	(52,621)
Acquisition of businesses, net of cash acquired	0	(327,581)
Other investing activities, net	894	3,448
Net cash used in investing activities	(29,274)	(376,754)
Cash flows from financing activities:
Proceeds from borrowings under Vail Holdings Credit Agreement	0	492,625
Proceeds from borrowings under Whistler Credit Agreement	18,021	0
Repayments of borrowings under Vail Holdings Credit Agreement	(15,625)	(175,000)
Repayments of borrowings under Whistler Credit Agreement	(3,834)	(7,529)
Employee taxes paid for share award exercises	(7,060)	(8,842)
Dividends paid	0	(71,091)
Repurchases of common stock	0	(21,444)
Other financing activities, net	(4,186)	(10,279)
Net cash (used in) provided by financing activities	(12,684)	198,440
Effect of exchange rate changes on cash, cash equivalents and restricted cash	254	939
Net increase in cash, cash equivalents and restricted cash	70,289	31,964
Cash, cash equivalents and restricted cash:
Beginning of period	402,086	118,389
End of period	472,375	150,353
Accrued capital expenditures	$ 18,132	$ 32,038